Furthermore, after comprehensive literature searching, we found that the VEGF gene polymorphism was closely associated with the occurrence, clinical therapeutic effects and prognosis for both lung cancer and breast cancer [46–52]. The gene discussed is VEGFA; the disease is breast carcinoma.